skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

The radioresistance of glioblastoma presumably results from the presence of hypoxic cells. In an attempt to overcome this problem, fast neutrons were compared in a controlled pilot study with conventional megavoltage x-rays (photons). 63 patients entered the study between January, 1973 and July, 1976, 30 patients received neutron and 33 received x-ray therapy. The overall mean survival was 11.4 months for those who received photon and 10 months for those who received neutron therapy. Survival rates at 6 and 12 months were 72 and 36% respectively for photon treated patients, and 77 and 30% for those treated with neutrons. Although neutron therapy did not improve overall survival, examination of the histological material indicated a considerably greater antitumor effect after neutron therapy than after treatment with photons. In the neutron treated group, at post-mortem examination no tumor or only minimal tumor was found in 10 of 12 patients and in one of 4 patients where tissue was obtained from a second craniotomy. In some cases, there was evidence of diffuse damage to normal brain which was in keeping with a clinical syndrome of progressive dementia without localizing signs. Dose, time, and volume factors for neutron therapy to the brain and possible ways of improving results are discussed.

OSTI ID:
5006183
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 6:3
Country of Publication:
United States
Language:
English

Similar Records

Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
Journal Article · Thu Nov 01 00:00:00 EDT 2012 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5006183

Rad51 Protein Expression and Survival in Patients with Glioblastoma Multiforme
Journal Article · Wed Jul 15 00:00:00 EDT 2009 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5006183

Fast neutron beam radiotherapy of glioblastoma multiforme
Conference · Sun Aug 01 00:00:00 EDT 1976 · Am. J. Roentgenol.; (United States) · OSTI ID:5006183